Skip to main content Accessibility Statement

News

September 26, 2022
Tactile Medical to Release Third Quarter of Fiscal Year 2022 Financial Results on November 7, 2022
MINNEAPOLIS , Sept. 26, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that third quarter of
Read more
September 6, 2022
Tactile Medical to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
MINNEAPOLIS , Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will
Read more
August 1, 2022
Tactile Systems Technology, Inc. Reports Second Quarter 2022 Financial Results; Raises Full Year 2022 Outlook
Second Quarter Revenue Increased 17% Year-Over-Year; First Half Revenue Increased 15% Year-Over-Year MINNEAPOLIS , Aug. 01, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the
Read more
July 25, 2022
Tactile Medical Introduces New ComfortEase™ Flexitouch® Plus Garments and Kylee™ Mobile Application
Flexitouch Plus garments redesigned to improve the patient experience; the Kylee app empowers patients through digital health monitoring MINNEAPOLIS , July 25, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on
Read more
July 12, 2022
Tactile Medical to Release Second Quarter of Fiscal Year 2022 Financial Results on August 1, 2022
MINNEAPOLIS , July 12, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that second quarter of
Read more
June 7, 2022
Tactile Medical Announces Publication of Expert Opinion Consensus Statement in Phlebology Recommending the Use of Pneumatic Compression for Lymphedema
Consensus that Patients with Chronic Venous Insufficiency Should be Considered Lymphedema Patients MINNEAPOLIS , June 07, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the
Read more
May 25, 2022
Tactile Medical to Present at the William Blair 42nd Annual Growth Stock Conference
MINNEAPOLIS , May 25, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will
Read more
May 2, 2022
Tactile Systems Technology, Inc. Reports First Quarter 2022 Financial Results; Reaffirms Full Year 2022 Outlook
First Quarter Revenue Increased 12% Year-Over-Year MINNEAPOLIS , May 02, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases
Read more
March 31, 2022
Tactile Medical to Release First Quarter of Fiscal Year 2022 Financial Results on May 2, 2022
MINNEAPOLIS , March 31, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that first quarter of
Read more
March 7, 2022
Tactile Medical to Participate in the Oppenheimer Healthcare Conference
MINNEAPOLIS , March 07, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will
Read more
Displaying 1 - 10 of 15